Detalhe da pesquisa
1.
Temporal Considerations in Brain Metastases Radiation Therapy: The Intersection of Chronobiology and Patient Profiles.
Clocks Sleep;
6(1): 200-210, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38534802
2.
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.
bioRxiv;
2024 May 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38766099
3.
Time Matters: Importance of Circadian Rhythms, Disruption, and Chronotherapy in Urologic Malignancies.
Urology;
175: 6-12, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36693529
4.
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer.
bioRxiv;
2023 Mar 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36993449
5.
Cistrome and transcriptome analysis identifies unique androgen receptor (AR) and AR-V7 splice variant chromatin binding and transcriptional activities.
Sci Rep;
12(1): 5351, 2022 03 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35354884
6.
Mutant p53 elicits context-dependent pro-tumorigenic phenotypes.
Oncogene;
41(3): 444-458, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34773073
7.
Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer.
Cancer Res;
82(2): 221-234, 2022 01 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34625422
8.
A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer.
Clin Cancer Res;
28(7): 1446-1459, 2022 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35078861
9.
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair.
Nat Commun;
12(1): 401, 2021 01 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33452241
10.
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease.
Cancer Discov;
11(9): 2334-2353, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33879449
11.
USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA Repair.
Cancer Res;
80(3): 430-443, 2020 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31740444
12.
Cancer and the Circadian Clock.
Cancer Res;
79(15): 3806-3814, 2019 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31300477
13.
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies.
Clin Cancer Res;
25(18): 5623-5637, 2019 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31266833
14.
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response.
Eur Urol Oncol;
1(4): 325-337, 2018 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30467556
15.
PARP-1 regulates DNA repair factor availability.
EMBO Mol Med;
10(12)2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30467127
16.
Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
Oncotarget;
6(31): 31997-2012, 2015 Oct 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26378018
17.
Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells.
Int J Biochem Cell Biol;
54: 49-59, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25008967
18.
Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression.
Steroids;
78(6): 548-54, 2013 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23380368
19.
Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
Pharmacol Ther;
140(3): 223-38, 2013 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23859952
20.
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression.
Int J Oncol;
42(1): 35-43, 2013 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23152004